Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$506.34 USD

506.34
1,041,901

+2.50 (0.50%)

Updated Nov 1, 2024 03:59 PM ET

After-Market: $506.75 +0.41 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Intuitive Surgical (ISRG) Gains on Strength in Robotics

Higher adoption of Intuitive Surgical's (ISRG) robot-based da Vinci system and increasing procedure volumes are key catalysts at the moment.

    Myriad Genetics' Prolaris Expands on New Coverage Decisions

    This increased rate in commercial insurer coverage for Myriad Genetics' (MYGN) Prolaris comes close on the heels of the NCCN guidelines.

      McKesson (MCK) Q4 Earnings Miss, International Sales Rise

      McKesson (MCK) posts strong segmental performance and issues encouraging guidance for fiscal 2019.

        Here's Why You Should Buy Boston Scientific (BSX) Stock Now

        Boston Scientific's (BSX) inorganic expansion plan bodes well for operational growth.

          Abbott Gets FDA Nod for XIENCE Sierra, To Boost Vascular Wing

          Abbott (ABT) continues with the slew of developments in regards with the XIENCE Sierra coronary stent system.

            Medtronic (MDT) Q4 Earnings: Can Spine Division Turn Around?

            Medtronic (MDT) expects to demonstrate positive outcome related to its distribution relationship with Mazor Robotics.

              Zimmer Biomet New System Gets FDA Nod, to Boost Spine Wing

              Zimmer Biomet (ZBH) receives FDA's approval for the new system, which is likely to augment the company's lumbar spacers portfolio.

                Cardiovascular Systems Rides on New Products Amid Tight Race

                Cardiovascular Systems (CSII) gains traction from a strong third-quarter fiscal 2018, witnessing a year-over-year revenue rise at both CAD and PAD businesses.

                  Will Solid Diabetes Arm Drive Medtronic's (MDT) Q4 Earnings?

                  Medtronic (MDT) is poised to gain on strength in Diabetes business in Q4 on continued uptake of MiniMed 670G system in the United States along with enhanced sensor supply capacity.

                    ResMed Releases Positive U.S. & U.K. Study Data on COPD

                    ResMed (RMD) presents the company-sponsored health economic studies, Home Oxygen Therapy-Home Mechanical Ventilation (HOT-HMV), at the ATS 2018 International Conference.

                      Here's Why You Should Invest in Illumina (ILMN) Stock Now

                      Illumina (ILMN) gains ground on product launches and international prospects.

                        Will Strong RTG Arm Drive Medtronic's (MDT) Q4 Earnings?

                        Medtronic (MDT) is poised to gain on continued strength in RTG business in Q4.

                          Varian Medical (VAR) Merges With Brazil MOH to Fight Cancer

                          Varian Medical (VAR) opts to spread radiotherapy accessibility in Latin America through Brazil MOH, other international ventures of the company hold promise.

                            Here's Why You Should Steer Clear of Cerner (CERN) for Now

                            Cerner's (CERN) downbeat view for 2018 and soft Q1 results fail to cheer investors.

                              Here's Why You Should Sell DENTSPLY SIRONA (XRAY) Stock Now

                              A rapidly changing healthcare environment in the United States, sluggish first quarter, declining margins and foreign exchange headwinds continue to hurt DENTSPLY SIRONA (XRAY).

                                QIAGEN (QGEN) Banks on Test Menu Expansion, Competition Stiff

                                QIAGEN's (QGEN) top line continues to gain on expanding test menu amid stiff competition and declining HPV sales.

                                  Medtronic Initiates Study on DES for Expanded Use in the US

                                  Medtronic (MDT) focuses on boosting CSH segment. Notably, successful results from The Bifurcation Cohort study will help the company to achieve expanded FDA approval for the Resolute Onyx DES.

                                    Intuitive Surgical (ISRG) Up 4.9% Since Earnings Report: Can It Continue?

                                    Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                      Illumina Takes Over Edico Genome, Fortifies NGS Platform

                                      Illumina (ILMN) proceeds with deals to boost NGS platform.

                                        BioScrip's Core Business Strong Despite Reimbursement Issues

                                        BioScrip (BIOS) consistently advances with its multi-faceted CORE plan to perk up the money matters. However, reimbursement cuts pertaining to 21st century Cures Act might hinder growth in 2018.

                                          Mellanox Technologies, MGM Resorts International, BP, Texas Instruments and Intuitive Surgical highlighted as Zacks Bull and Bear of the Day

                                          Mellanox Technologies, MGM Resorts International, BP, Texas Instruments and Intuitive Surgical highlighted as Zacks Bull and Bear of the Day

                                            GNC Holdings' Global Prospects Solid, Competition Stiff

                                            GNC Holdings (GNC) progresses with deals to boost international presence.

                                              CryoLife (CRY) Stock Gains 9.5% on Impressive Q1 Earnings

                                              CryoLife's (CRY) shares gain on growth in all product lines along with strong performance in all geographies in Q1.

                                                TransEnterix (TRXC) Soars: Stock Adds 14.2% in Session

                                                TransEnterix (TRXC) saw a big move last session, as its shares jumped more than 14% on the day, amid huge volumes.

                                                  Orthofix (OFIX) Stock Declines 13% on '18 Earnings View Cut

                                                  Despite the bottom line of Orthofix (OFIX) betters estimates, the company's shares drop due to trimmed 2018 earnings outlook.